MaxCyte(MXCT) - 2025 Q4 - Earnings Call Transcript

MaxCyte (NasdaqGS:MXCT) Q4 2025 Earnings call March 24, 2026 04:30 PM ET Company ParticipantsDouglas Swirsky - CFOErik Abdo - Director of Investor RelationsMaher Masoud - President and CEOSean Menarguez - Senior Director of Business DevelopmentVidyun Bais - VP in Equity ResearchConference Call ParticipantsChad Wiatrowski - AnalystDan Arias - Managing Director & Senior Equity Research AnalystJacob Johnson - AnalystMatt Etoch - Research AnalystMatt Hewitt - Senior Research AnalystOperatorPlease note, this con ...